{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T01:13:47Z","timestamp":1762996427924,"version":"3.45.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,12]]},"DOI":"10.7759\/cureus.96707","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T01:08:59Z","timestamp":1762996139000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Safety and Effectiveness of Perispinal Etanercept for Post-Stroke Recovery: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Meha","family":"Sanghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawat","family":"Khanijoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahla","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","author":"GBD 2019 Stroke Collaborators","year":"2021","unstructured":"GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021, 20:795-820. 10.1016\/S1474-4422(21)00252-0","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30962-X","article-title":"Stroke","volume":"389","author":"Hankey GJ","year":"2017","unstructured":"Hankey GJ. Stroke. Lancet. 2017, 389:641-54. 10.1016\/S0140-6736(16)30962-X","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000098","article-title":"Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"47","author":"Winstein CJ","year":"2016","unstructured":"Winstein CJ, Stein J, Arena R, et al.. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2016, 47:e98-e169. 10.1161\/STR.0000000000000098","journal-title":"Stroke"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186454","article-title":"Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches","volume":"21","author":"Maida CD","year":"2020","unstructured":"Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A. Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches. Int J Mol Sci. 2020, 21:6454. 10.3390\/ijms21186454","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0174-2","article-title":"Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence","volume":"28","author":"Ignatowski TA","year":"2014","unstructured":"Ignatowski TA, Spengler RN, Dhandapani KM, Folkersma H, Butterworth RF, Tobinick E. Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence. CNS Drugs. 2014, 28:679-97. 10.1007\/s40263-014-0174-2","journal-title":"CNS Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00626.x","article-title":"Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics","volume":"223","author":"Feldmann M","year":"2008","unstructured":"Feldmann M, Maini SR. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev. 2008, 223:7-19. 10.1111\/j.1600-065X.2008.00626.x","journal-title":"Immunol Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1276376","article-title":"Treatment of Parkinson's disease with biologics that penetrate the blood-brain barrier via receptor-mediated transport","volume":"15","author":"Pardridge WM","year":"2023","unstructured":"Pardridge WM. Treatment of Parkinson's disease with biologics that penetrate the blood-brain barrier via receptor-mediated transport. Front Aging Neurosci. 2023, 15:1276376. 10.3389\/fnagi.2023.1276376","journal-title":"Front Aging Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2008.10.005","article-title":"Perispinal etanercept for neuroinflammatory disorders","volume":"14","author":"Tobinick E","year":"2009","unstructured":"Tobinick E. Perispinal etanercept for neuroinflammatory disorders. Drug Discov Today. 2009, 14:168-77. 10.1016\/j.drudis.2008.10.005","journal-title":"Drug Discov Today"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-012-0013-2","article-title":"Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept","volume":"26","author":"Tobinick E","year":"2012","unstructured":"Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, DePuy V. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs. 2012, 26:1051-70. 10.1007\/s40263-012-0013-2","journal-title":"CNS Drugs"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2165\/11588400-000000000-00000","article-title":"Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases","volume":"25","author":"Tobinick E","year":"2011","unstructured":"Tobinick E. Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases. CNS Drugs. 2011, 25:145-55. 10.2165\/11588400-000000000-00000","journal-title":"CNS Drugs"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-019-00864-8","article-title":"Immediate resolution of hemispatial neglect and central post-stroke pain after perispinal etanercept: case report","volume":"40","author":"Tobinick E","year":"2020","unstructured":"Tobinick E. Immediate resolution of hemispatial neglect and central post-stroke pain after perispinal etanercept: case report. Clin Drug Investig. 2020, 40:93-7. 10.1007\/s40261-019-00864-8","journal-title":"Clin Drug Investig"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0057-y","article-title":"Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept","volume":"27","author":"Page SJ","year":"2013","unstructured":"Page SJ. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs. 2013, 27:395-7. 10.1007\/s40263-013-0057-y","journal-title":"CNS Drugs"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213981","article-title":"Safety and efficacy of perispinal etanercept for chronic stroke: a randomized clinical trial","volume":"105","author":"Thijs VN","year":"2025","unstructured":"Thijs VN, Cloud GC, Gilchrist N, et al.. Safety and efficacy of perispinal etanercept for chronic stroke: a randomized clinical trial. Neurology. 2025, 105:e213981. 10.1212\/WNL.0000000000213981","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1709822","article-title":"Phase I\/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation","volume":"29","author":"Ralph SJ","year":"2020","unstructured":"Ralph SJ, Weissenberger A, Bonev V, et al.. Phase I\/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation. Expert Opin Investig Drugs. 2020, 29:311-26. 10.1080\/13543784.2020.1709822","journal-title":"Expert Opin Investig Drugs"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref17","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2021). Accessed. October 13, 2025: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref18","article-title":"Chapter 7: Systematic reviews of etiology and risk","author":"Moola S","year":"2020","unstructured":"Moola S, Munn Z, Tufanaru C, et al.. Chapter 7: Systematic reviews of etiology and risk. JBI Reviewer's Manual. Aromataris E, Munn Z (ed): Joanna Briggs Institute, Adelaide; 2020."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3511385","article-title":"Pharmacotherapies for central post-stroke pain: a systematic review and network meta-analysis","volume":"2022","author":"Bo Z","year":"2022","unstructured":"Bo Z, Jian Y, Yan L, et al.. Pharmacotherapies for central post-stroke pain: a systematic review and network meta-analysis. Oxid Med Cell Longev. 2022, 2022:3511385. 10.1155\/2022\/3511385","journal-title":"Oxid Med Cell Longev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.2.184","article-title":"Lamotrigine for central poststroke pain: a randomized controlled trial","volume":"56","author":"Vestergaard K","year":"2001","unstructured":"Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. 2001, 56:184-90. 10.1212\/wnl.56.2.184","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.62.5_suppl_2.s30","article-title":"Evaluation and treatment of central pain syndromes","volume":"62","author":"Nicholson BD","year":"2004","unstructured":"Nicholson BD. Evaluation and treatment of central pain syndromes. Neurology. 2004, 62:S30-6. 10.1212\/wnl.62.5_suppl_2.s30","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-025-02803-5","article-title":"Efficacy and safety of corticosteroids for stroke and traumatic brain injury: a systematic review and meta-analysis","volume":"14","author":"Wang Y","year":"2025","unstructured":"Wang Y, Huang L, Li J, et al.. Efficacy and safety of corticosteroids for stroke and traumatic brain injury: a systematic review and meta-analysis. Syst Rev. 2025, 14:54. 10.1186\/s13643-025-02803-5","journal-title":"Syst Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.587050","article-title":"Opioids in post-stroke pain: a systematic review and meta-analysis","volume":"11","author":"Scuteri D","year":"2020","unstructured":"Scuteri D, Mantovani E, Tamburin S, Sandrini G, Corasaniti MT, Bagetta G, Tonin P. Opioids in post-stroke pain: a systematic review and meta-analysis. Front Pharmacol. 2020, 11:587050. 10.3389\/fphar.2020.587050","journal-title":"Front Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.926","article-title":"Chronic cerebral aspects of long COVID, post-stroke syndromes and similar states share their pathogenesis and perispinal etanercept treatment logic","volume":"10","author":"Clark IA","year":"2022","unstructured":"Clark IA. Chronic cerebral aspects of long COVID, post-stroke syndromes and similar states share their pathogenesis and perispinal etanercept treatment logic. Pharmacol Res Perspect. 2022, 10:e00926. 10.1002\/prp2.926","journal-title":"Pharmacol Res Perspect"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/433158-evaluating-the-safety-and-effectiveness-of-perispinal-etanercept-for-post-stroke-recovery-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T01:08:59Z","timestamp":1762996139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/433158-evaluating-the-safety-and-effectiveness-of-perispinal-etanercept-for-post-stroke-recovery-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.96707","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,12]]}}}